🇺🇸 AMGN — Amgen Inc.

Healthcare Compra
← Volver

Precio actual

437,23 USD

Máx. histórico

447,03

10 días

Split 2:1 del 22/11/1999

Caída desde máximo

-2,19%

Rango 52 semanas

269,77 – 447,03

Variación hoy

-1,55%

Cierre anterior

444,12

Rango de hoy

435,01 – 441,66

Volumen hoy

1.656.089

Información
Nombre completo
Amgen Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Healthcare
Industria
Drug Manufacturers - General
Empleados
31.500
PER ⓘ
27,17 (puede no estar actualizado)
Dividend yield
2,31% (puede no estar actualizado)
Precio objetivo analistas
389,69 USD (puede no estar actualizado)
Primera cotización
17/06/1983
Precio actualizado
hace 3 días
Sobre la empresa

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. The company's principal products include Enbrel for the treatment of rheumatoid arthritis, plaque psoriasis, and psoriatic arthritis; Otezla for the treatment of adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçet's disease; Prolia to treat postmenopausal women with osteoporosis; XGEVA for skeletal-related events prevention; Repatha, which reduces the risks of myocardial infarction, stroke, and coronary revascularization; Nplate for the treatment of patients with immune thrombocytopenia; KYPROLIS to treat patients with relapsed or refractory multiple myeloma; Aranesp to treat a lower-than-normal number of red blood cells and anemia; EVENITY for the treatment of osteoporosis in postmenopausal for women; Vectibix to treat patients with wild-type RAS metastatic colorectal cancer; BLINCYTO for the treatment of patients with acute lymphoblastic leukemia; TEPEZZA to treat thyroid eye disease; and KRYSTEXXA for the treatment of chronic refractory gout. It also markets other products, including PROLIA, REPATHA, OTEZLA, ENBREL, EVENITY, XGEVA, TEPEZZA, BLINCYTO, NPLATE, TEZSPIRE, KYPROLIS, ARANESP, KRYSTEXXA AND VECTIBIX, MVASI, PAVBLU, UPLIZNA, IMDELLTRA/IMDYLLTRA, AMJEVITA/AMGEVITA, TAVNEOS, NEULASTA, LUMAKRAS/LUMYKRAS, RAVICTI, PARSABIV, AIMOVIG, WEZLANA/WEZENLA, AND PROCYSBI. The company serves healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies. It distributes its products through pharmaceutical wholesale distributors. The company has collaboration agreements with AstraZeneca plc for the development and commercialization of TEZSPIRE; BEONE MEDICINES LTD. to develop and commercialize Aimovig; UCB for the development and commercialization of EVENITY; Kyowa Kirin Co., Ltd. for rocatinlimab development and commercialization; and BeiGene, Ltd. for oncology products expansion and development. The company was incorporated in 1980 and is headquartered in Thousand Oaks, California.

Dividendos repartidos Total últimos 12 meses: 9,9400 USD · Yield: 2,27%
Fecha de pago Importe por participación
21/08/2026 2,5200 USD
15/05/2026 2,5200 USD
13/02/2026 2,5200 USD
21/11/2025 2,3800 USD
22/08/2025 2,3800 USD
16/05/2025 2,3800 USD
14/02/2025 2,3800 USD
18/11/2024 2,2500 USD
16/08/2024 2,2500 USD
16/05/2024 2,2500 USD
15/02/2024 2,2500 USD
16/11/2023 2,1300 USD
17/08/2023 2,1300 USD
17/05/2023 2,1300 USD
14/02/2023 2,1300 USD
Splits Registrados en el histórico de precios
Fecha Ratio
22/11/1999 2:1
01/03/1999 2:1
16/08/1995 2:1
11/09/1991 3:1
13/08/1990 2:1
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
23/08/2011 52,36 53,62 52,22 53,62 +2,50% 2,67% 7.806.600
22/08/2011 52,42 53,00 52,20 52,31 +0,63% 1,53% 9.289.800
19/08/2011 50,79 52,42 50,74 51,98 +1,05% 3,31% 9.437.000
18/08/2011 50,65 51,68 50,63 51,44 -0,54% 2,07% 10.138.400
17/08/2011 51,30 51,80 51,29 51,72 +0,88% 0,99% 8.150.100
16/08/2011 51,25 51,70 50,85 51,27 -0,64% 1,66% 6.630.400
15/08/2011 50,48 51,68 50,18 51,60 +3,20% 2,97% 7.665.700
12/08/2011 49,71 50,67 49,55 50,00 +0,73% 2,25% 7.919.700
11/08/2011 48,12 50,10 47,66 49,64 +2,84% 5,07% 14.860.500
10/08/2011 49,58 49,94 48,08 48,27 -4,51% 3,75% 12.558.400
09/08/2011 50,01 50,79 48,50 50,55 +1,34% 4,58% 16.124.400
08/08/2011 51,66 52,44 49,88 49,88 -4,30% 4,96% 13.911.500
05/08/2011 51,82 52,97 51,23 52,12 +1,09% 3,36% 9.914.200
04/08/2011 52,60 53,15 51,54 51,56 -3,30% 3,06% 9.918.500
03/08/2011 53,35 53,43 52,35 53,32 +0,02% 2,02% 7.145.700
02/08/2011 53,39 54,25 53,21 53,31 -0,86% 1,95% 7.526.200
01/08/2011 55,02 55,28 53,05 53,77 -1,70% 4,05% 8.875.500
29/07/2011 54,73 55,20 53,05 54,70 +2,38% 3,93% 10.640.200
28/07/2011 53,64 54,65 53,33 53,43 -0,69% 2,46% 6.586.100
27/07/2011 54,50 54,95 53,61 53,80 -1,65% 2,46% 6.502.800
26/07/2011 54,77 55,07 54,42 54,70 -0,36% 1,19% 4.428.200
25/07/2011 55,22 55,36 54,71 54,90 -0,58% 1,18% 3.174.100
22/07/2011 55,35 55,46 55,01 55,22 -0,49% 0,81% 3.098.400
21/07/2011 55,33 55,92 55,02 55,49 +0,91% 1,63% 5.539.600
20/07/2011 55,28 55,42 54,93 54,99 -0,51% 0,89% 4.151.300
19/07/2011 55,01 55,51 54,87 55,27 +1,12% 1,16% 4.977.000
18/07/2011 55,12 55,26 54,31 54,66 -0,71% 1,72% 6.241.800
15/07/2011 55,37 55,42 54,74 55,05 -1,13% 1,23% 9.209.200
14/07/2011 56,56 56,60 55,49 55,68 -1,64% 1,96% 7.201.300
13/07/2011 56,98 57,23 56,35 56,61 -0,51% 1,54% 4.514.200